Exchange: NASDAQ·Updated 07:41 PM EDT
ESPR logo

ESPR Esperion Therapeutics Inc.

$3.18
$0.01
(0.31%)
Today
Closed $3.18
$0.00
(0.00%)
After Hours
Reported EarningsMay 8
Mkt Cap$819.46M
Vol59.09M

About ESPR

Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.
74

Bullish Sentiment

How do you feel about ESPR?

Advertisement|Remove ads.